Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults-Reference-Cited by-同舟云学术

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

Published:2022-07-11 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Niyomnaitham Suvimol¹²,Quan Toh Zheng³⁴,Wongprompitak Patimaporn⁵,Jansarikit Laddawan²,Srisutthisamphan Kanjana⁶,Sapsutthipas Sompong⁷,Jantraphakorn Yuparat⁶,Mingngamsup Natthakarn⁷,Licciardi Paul V³⁴,Chokephaibulkit Kulkanya¹⁸^ORCID

Affiliation:

1. Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

2. Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

3. Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia

4. Department of Pediatrics, The University of Melbourne, Parkville, Victoria, Australia

5. Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

6. National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science Development Agency (NSTDA), Pathum thani, Thailand

7. Department of Medical Sciences, Institute of Biological Products, Bangkok, Thailand

8. Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Funder

no funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2091865

Reference34 articles.

1. Worldometer. COVID-19 coronavirus pandemic. 2019. [accessed 2022 Apr 1]. https://www.worldometers.info/coronavirus/

2. The New York Times. Tracking Coronavirus Vaccinations Around the World. 2022. [accessed 2022 Apr 1]. https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html

3. How COVID vaccines shaped 2021 in eight powerful charts

4. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis

5. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waning Humoral Immune Response Following the Third and Fourth SARS‐COV‐2 Vaccine: A Cohort Study in Healthcare Workers;Influenza and Other Respiratory Viruses;2024-08-27

2. Effectiveness of COVID-19 vaccination in breastfeeding women in preventing SARS-CoV-2 infection in infants;2024-08-26

3. Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand;Vaccine: X;2024-06

4. Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12–17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination;Vaccine;2024-04

5. Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus;Lupus;2024-02-09